RCEL

#3381
Avita Medical, Inc. - Common Stock
4.3 3 USD
-1.37%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
4.33
4.33
Range Annuel
3.22
7.12
Changement quotidien
-1.37%
Changement Mensuel
+1.64%
Evolution sur 6 mois
+17.03%
Changement Annuel
-25.34%
Clôture Précédente
4.3 9
Open
4.3 3
Low
4.3 3
High
4.3 3
Volume
19
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
  • Market Capitalization 133.26 M
  • Employee 226
  • Founded 1999
  • CEO James Corbett
  • Website www.avitamedical.com
  • Headquarter Delaware, United States
  • FIGI BBG00TD18T43
  • Industry Dispositifs Médicaux
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-1.98
ratio cours/chiffre d'affaires
1.34

Avita Medical, Inc. - Common Stock

Avita Medical is a clinical and commercial company developing and marketing a range regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are ReNovaCell, for Aesthetics and Plastic applications including skin trauma, and ReGenerCell for the treatment of chronic wounds. The Avita Medical regenerative product range is currently marketed in Europe, the Middle East, Africa and Australia.

Nouvelles